What is the significance and recommended work‑up for a male with hemoglobin 18.5 g/dL and hematocrit 54.4 %?

Elevated Hemoglobin and Hematocrit in a Male Patient

This male patient meets the WHO diagnostic threshold for polycythemia vera (PV) with hemoglobin 18.5 g/dL and hematocrit 54.4%, and requires immediate JAK2 mutation testing along with serum erythropoietin level to establish the diagnosis. 1

Diagnostic Significance

The values Hb 18.5 g/dL and Hct 54.4% precisely meet the first major criterion for polycythemia vera according to WHO 2016 criteria, which defines the threshold as hemoglobin >16.5 g/dL in men or hematocrit >49% in men 2. The 2007 WHO revision specifically established hemoglobin ≥18.5 g/dL in men as the diagnostic cutoff for PV 1.

Immediate Work-Up Algorithm

First-Line Testing (Order Immediately):

1. JAK2 V617F mutation testing - This is the second major criterion for PV diagnosis and is present in >95% of PV cases 1

   • If positive: Proceed to confirm PV diagnosis
   • If negative: Test for JAK2 exon 12 mutations 1

2. Serum erythropoietin level - This is a minor criterion; levels below normal reference range support PV diagnosis 1, 2

3. Complete iron studies - Critical because iron deficiency can mask the true hemoglobin elevation in PV patients 1

Second-Line Testing:

1. Bone marrow biopsy - Required if JAK2 is negative or if diagnostic uncertainty exists
   • Look for: hypercellularity for age with trilineage growth (panmyelosis) with prominent erythroid, granulocytic, and megakaryocytic proliferation 1, 2

Diagnostic Criteria Application

PV diagnosis requires:

• Both major criteria (Hb ≥18.5 g/dL + JAK2 mutation) PLUS 1 minor criterion, OR
• First major criterion (Hb ≥18.5 g/dL) PLUS 2 minor criteria 1, 2

Minor criteria include:

• Bone marrow biopsy showing panmyelosis
• Subnormal serum erythropoietin level
• Endogenous erythroid colony formation in vitro 1

Critical Pitfalls to Avoid

Iron deficiency masking: If iron deficiency is present, the hemoglobin may be artificially lowered. In routine clinical practice, you should not be prevented from making a working diagnosis of PV in the presence of iron deficiency, even if WHO criteria aren't fully met after iron replacement 1. However, for formal diagnosis in research settings, demonstrate meeting WHO criteria after iron repletion.

Secondary causes: Before confirming primary PV, exclude secondary erythrocytosis causes:

• Hypoxia (sleep apnea, chronic lung disease, high altitude residence, smoking) - most common in young adults 3
• Renal pathology (renal artery stenosis, renal tumors)
• Other tumors producing erythropoietin
• Testosterone use or other performance-enhancing drugs

Relative vs. absolute erythrocytosis: Consider plasma volume measurement if clinical picture suggests relative (spurious) erythrocytosis, though this is less common at these hemoglobin levels 3.

Clinical Context

In a retrospective study of young adults with elevated hemoglobin, secondary erythrocytosis (particularly hypoxia-related) was the most frequent etiology identified, with no primary erythrocytosis found in that cohort 3. However, this patient's values precisely meet PV diagnostic thresholds, making primary evaluation essential.

The management approach differs significantly based on whether this is primary (PV) versus secondary erythrocytosis, as PV carries thrombotic risks requiring aspirin therapy and potentially phlebotomy or cytoreductive therapy, while secondary causes require addressing the underlying etiology.